Next report date
Report period
Q1 2024
EPS estimate
−2.32MXN
Revenue estimate
13.26 MMXN
−9.77MXN
−1.40 BMXN
125.33 MMXN
174.51 M
About Vaxart, Inc. - Common Stock
Sector
Industry
CEO
Steven Lo
Website
Headquarters
South San Francisco
Employees (FY)
125
Founded
2004
FIGI
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded in 2004 and is headquartered in South San Francisco, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VXRT is 21.00 MXN — it has increased by 2.44% in the past 24 hours. Watch VAXART, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange VAXART, INC stocks are traded under the ticker VXRT.
VAXART, INC is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
VXRT stock is 2.81% volatile and has beta coefficient of 1.95. Track VAXART, INC stock price on the chart and check out the list of the most volatile stocks — is VAXART, INC there?
VXRT earnings for the last quarter are −1.92 MXN per share, whereas the estimation was −3.14 MXN resulting in a 38.89% surprise. The estimated earnings for the next quarter are −2.26 MXN per share. See more details about VAXART, INC earnings.
VAXART, INC revenue for the last quarter amounts to 36.62 M MXN despite the estimated figure of 1.74 M MXN. In the next quarter revenue is expected to reach 14.15 M MXN.
Yes, you can track VAXART, INC financials in yearly and quarterly reports right on TradingView.
VXRT stock has fallen by 0.43% compared to the previous week, the month change is a 0.96% rise, over the last year VAXART, INC has showed a 3.45% decrease.
VXRT net income for the last quarter is −295.12 M MXN, while the quarter before that showed −303.29 M MXN of net income which accounts for 2.70% change. Track more VAXART, INC financial stats to get the full picture.
Today VAXART, INC has the market capitalization of 2.11 B, it has increased by 8.27% over the last week.
No, VXRT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VXRT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VAXART, INC stock right from TradingView charts — choose your broker and connect to your account.
As of May 2, 2024, the company has 125.00 employees. See our rating of the largest employees — is VAXART, INC on this list?
We've gathered analysts' opinions on VAXART, INC future price: according to them, VXRT price has a max estimate of 133.24 MXN and a min estimate of 33.31 MXN. Watch VXRT chart and read a more detailed VAXART, INC stock forecast: see what analysts think of VAXART, INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VAXART, INC EBITDA is −1.34 B MXN, and current EBITDA margin is −1.07 K%. See more stats in VAXART, INC financial statements.